INIS
communities
100%
staphylococcus
100%
tissues
66%
skin
66%
patients
50%
therapy
16%
risks
16%
children
16%
sensitivity
16%
antibiotics
16%
values
16%
specificity
16%
nose
16%
Medicine and Dentistry
Methicillin Resistant Staphylococcus Aureus
66%
Patient
66%
Skin
66%
Methicillin Resistant Staphylococcus Aureus Infection
50%
Prospective Study
33%
Infection
33%
Staphylococcus aureus
33%
Prevalence
16%
Sensitivity and Specificity
16%
Antibiotic Therapy
16%
Predictor
16%
Staphylococcus Aureus
16%
Patient Isolation
16%
Aptitude
16%
Race
16%
Torso
16%
Nursing and Health Professions
Culture
100%
Soft Tissue Infection
66%
Methicillin Resistant Staphylococcus Aureus Infection
50%
Infection
33%
Methicillin-Resistant Staphylococcus Aureus
33%
Child
33%
Sensitivity and Specificity
16%
Prevalence
16%
Predictive Value
16%
Antibiotic Therapy
16%
Contact Isolation
16%
Patient Isolation
16%
Pharmacology, Toxicology and Pharmaceutical Science
Methicillin-Resistant Staphylococcus Aureus
66%
Soft Tissue Infection
66%
Methicillin Resistant Staphylococcus Aureus Infection
50%
Infection
33%
Prevalence
16%
Staphylococcus Aureus
16%